Licensed regenerative medicine, built for real outcomes.
Ciming Boao International Hospital delivers globally-aligned assisted reproductive technology and stem cell therapy — under China's most advanced special medical licensing policy, in Hainan's Boao Lecheng Pilot Zone.
A pilot demonstration hospital for public–private "licensed medical operation"
Focused on high-end, standard-setting medical services across four core disciplines.
Assisted Reproductive Technology
Full-spectrum licenses covering AIH, AID, IVF-ET, ICSI and PGT, backed by a nearly 5,000 ㎡ Reproductive Medicine Center.
Stem Cell Therapy for POI
Umbilical cord mesenchymal stem cell therapy for premature ovarian insufficiency.
Stem Cell Therapy for T2DM
Targeted intervention for Type 2 diabetes mellitus and metabolic disorders.
Chronic Disease Management
Full life-cycle testing, personalized conditioning and rehabilitation therapies for diabetes, cardiovascular and autoimmune conditions.
Grade-A tertiary resources, private-sector agility
Ciming Boao International Hospital — formally Lecheng Hospital, the First Affiliated Hospital of Hainan Medical University — is a core member of Dr. Han Regenerative Medical Group, founded in 2017 by Dr. Han Xiaohong, Chairperson of the Special Committee on Physician Health Management and Physician Health Insurance under the Chinese Medical Doctor Association.
In October 2022, the hospital signed a tripartite agreement with the First Affiliated Hospital of Hainan Medical University and the Administration Bureau of Boao Lecheng Pilot Zone, pioneering a "Public Institution, Private Operation" model that integrates Grade-A tertiary hospital resources with flexible private-sector operations.
- LocationBoao Lecheng International Medical Tourism Pilot Zone, Hainan
- Land area20,000 ㎡
- Construction area15,000 ㎡
- Laboratory standardClass 100 laminar flow
- Beds — initial phase82 beds
- Beds — planned501 beds
- Chief physicians36
- Associate chief physicians26
- Licensed practitioners203
- Overseas drugs / devices introduced570+ across 28 disciplines
- Patients benefited by zone policy200,000+
A decade building toward licensed regenerative care
Hospital officially founded, one of the first general hospitals in Boao Lecheng Pilot Zone.
Obtained Practice License for Grade-III General Medical Institution; launched health physical examination services.
Assisted reproductive technology approved for trial operation; international reproductive medicine team established.
PCR laboratory passed provincial inspection; first "Lecheng Ciming IVF baby" born; stem cell research agreement signed.
Added title "Lecheng Hospital, First Affiliated Hospital of Hainan Medical University."
Secured full range of assisted reproduction technology licenses: IVF-ET, ICSI, PGT, AID, AIH.
First ovarian tissue cryopreservation surgery in Boao Lecheng; Clinical Sub-center for Fertility Protection founded.
Stem cell therapy for premature ovarian insufficiency and Type 2 diabetes approved for clinical application.
One-stop fertility support, built to international standards
A nearly 5,000 ㎡ Reproductive Medicine Center houses 4 oocyte retrieval operating rooms, 4 embryo transfer rooms, and Class 100 laminar flow embryo and PGT laboratories — paired with GFG Fertility Clinic in Midtown Manhattan, New York, for Sino-US collaborative care.
- PRP endometrial regeneration therapy and microfluidic sperm sorting.
- Ovarian tissue cryopreservation for cancer patients and advanced-age women.
- PGT screening for 125 common chromosomal abnormalities to reduce birth-defect risk.
- Bilingual Chinese–English reports with dedicated specialist consultation.
Ovarian repair & targeted anti-aging
Officially approved by the Boao Lecheng Drug Regulatory Authority in August 2025 (Lecheng Medical Drug Supervision Bureau, document [2025] No.62) for the translational application of umbilical cord mesenchymal stem cell therapy for premature ovarian insufficiency.
Ovarian stem cells home to the ovaries and differentiate into follicular cells, exert a paracrine effect that promotes angiogenesis, and modulate immune response to reduce granulosa cell apoptosis.
Indicated for
Clinically diagnosed POI/POF, hypoestrogenic symptoms, diminished ovarian reserve, prior failed ART treatment.
Treatment goals
Repair ovarian damage, regulate menstrual cycle, alleviate menopausal symptoms, delay ovarian aging.
Observed outcomes
Elevated AMH and antral follicle counts, ovulation restoration in some patients, improved IVF/frozen-cycle success.
Data derived from real clinical case studies; treatment plans are subject to individual physician diagnosis.
Targeted intervention to reverse metabolic disorders
Approved by the Boao Lecheng Medical Drug Supervision Bureau in December 2025 (document [2025] No.113). Intravenous infusion of human umbilical cord mesenchymal stem cells works to restore pancreatic β-cell function, alleviate insulin resistance and regulate glucose metabolic balance — supporting dynamic diabetes management and complication prevention.
- May reduce HbA1c levels and the dosage of hypoglycemic agents.
- May improve pancreatic β-cell function, evidenced by elevated HOMA-β index.
- Good tolerability observed; transient fever is the main reported adverse reaction.
- No severe adverse reactions observed in subjects after treatment.
Treatment process
Pre-treatment evaluation
Online or in-person consultation, including blood glucose and HbA1c testing.
Personalized plan
Our medical team builds a treatment schedule and care plan for each patient's condition.
Treatment procedure
Each session takes about 1–2 hours under medical supervision using minimally invasive techniques.
Post-treatment follow-up
48-week follow-up and ongoing health management support.
Schedule: one session per week for 3 consecutive weeks, totaling 15 days.
Program pricing (by weight & cell count)
| Weight | Cell Count | Per-Session Fee | 3-Session Program Fee | Physician Consultation Fee | 1-Year Health Mgmt Fee |
|---|---|---|---|---|---|
| 45–54 kg | 5×10⁷ | ¥58,000 | ¥174,000 | ¥800 | ¥60,000 |
| 55–64 kg | 6×10⁷ | ¥69,600 | ¥208,800 | ¥800 | ¥60,000 |
| 65–74 kg | 7×10⁷ | ¥81,200 | ¥243,600 | ¥800 | ¥60,000 |
| 75 kg and above | 8×10⁷ | ¥92,800 | ¥278,400 | ¥800 | ¥60,000 |
Total fee = single/course price (by weight & cell count) + expert consultation fee + health management service fee. Excludes physical exams, accommodation, meals and other personal expenses. Health management fee is subject to actual service months.
Our medical team
Dr. Kaisi Zhu
Senior Physician, ProfessorDeputy Director, Endocrinology & Metabolism. Former Director, Beijing 305 Hospital. Professor of Endocrinology, Southern Medical University.
Shi Jianpeng
Associate Senior PhysicianVice President & Medical Expert, Ciming Boao. 30+ years of clinical, research and teaching experience.
Dr. Tao Shang
Senior Physician, Master of MedicineChief Physician, Endocrinology & Metabolism. Healthcare Physician for provincial-level officials, Jilin Province.
Dr. Dawei Peng
Senior Physician, ProfessorChief Expert, Ciming Boao. Review Expert for national ministry-level projects; interviewed by CCTV News.
Diabetes in China, by the numbers
Full-cycle precision health protection
A closed-loop service of precise testing, personalized regimen and full-cycle management, integrating cutting-edge international medical concepts with local clinical practice.
RMD Natural Medical Test
A Class II device imported from Hungary, detecting 11,000 indicators within 10 minutes — including cell testing, disease-risk assessment and monitoring of 72 types of emotional fluctuation. Certified in 50+ countries.
Personalized Conditioning
800+ in-depth regimens, including 24-hour detoxification and 28-day cell activation, targeting insomnia, chronic fatigue and immune disorders.
Applicable Population
Diabetes, cardiovascular and autoimmune disease patients, and sub-health populations with poor sleep or indigestion.
Specialized nutrition & rehabilitation therapies
| Therapy | Conditioning Efficacy | Applicable Population |
|---|---|---|
| Hepatic Nutrition Formula | Liver protection & detoxification, healthy blood lipids, fades pigmentation | Late-night workers, alcohol drinkers, drug-induced liver damage |
| Myocardial Nutrition Formula | Nourishes myocardium, relieves myocardial ischemia | Coronary heart disease, hypertension, arrhythmia |
| Neural Nutrition Formula | Boosts cerebral blood flow, improves sleep | Neurasthenia, insomnia, memory impairment |
| Cerebrovascular Nutrition Activation | Inhibits platelet aggregation, protects vascular endothelium | Cerebral thrombosis, cerebral arteriosclerosis sequelae |
| Youth Activation Therapy | Activates metabolism & immune system, clears lipid/glucose toxins | Sub-health, hyperlipidemia, anti-aging demand groups |
Plan your consultation
- AddressNo. 18 Kangxiang Road, Boao Lecheng International Medical Tourism Pilot Zone, Hainan Province, P.R. China
- Phone0898-36862698
- Websitewww.cimingboao.com
- Full nameCiming Boao International Hospital (Lecheng Hospital, First Affiliated Hospital of Hainan Medical University)
Information on this site is provided for general reference and reflects hospital-published materials as of 2026. Treatment eligibility, protocols and outcomes are determined by physicians on an individual basis. Stem cell therapies described are approved for translational clinical application under Boao Lecheng Pilot Zone special licensing policy.